Related Experiment Video
Updated: Jul 11, 2026

07:45
Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
Published on: January 26, 2024
Applying population dynamics modeling to patients with lymph node positive prostate cancer.
Peter A S Johnstone1, Robert H Riffenburgh, Peter J Rossi
1Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA. peter@radonc.emory.org
The Journal of Urology
|September 18, 2007
Summary
Prostate cancer patients with positive lymph nodes are not a doomed population. Population dynamics modeling revealed a 4-year window post-diagnosis for potentially curative therapies.
Area of Science:
- Oncology
- Mathematical Biology
- Public Health
Background:
- Cancer progression can be modeled using population dynamics, showing distinct phases from curable to incurable disease.
- An inflection point marks the transition to incurable disease, a critical factor in treatment strategy.
- Patients with lymph node-positive prostate cancer are often presumed to have a poor prognosis.
Purpose of the Study:
- To apply population dynamics models to prostate cancer patients with positive lymph nodes.
- To determine if these data support the presumption of incurable disease in this patient group.
- To identify potential windows for curative intervention using survival data analysis.
Main Methods:
- Utilized Surveillance, Epidemiology, and End Results (SEER) Registry data from 1988-1993 for men with nonmetastatic prostate cancer and positive lymph nodes.
- Modeled survival data using Gompertzian and exponential mathematical models.
- Analyzed data to identify the existence and timing of a disease inflection point.
Main Results:
- Gompertzian modeling provided the best fit for the survival data of 2,265 patients.
- An inflection point was identified 4 years after diagnosis in the modeled patient population.
- This inflection suggests a critical 4-year period for initiating curative treatment.
Conclusions:
- Patients with lymph node-positive prostate cancer should not be considered a uniformly doomed population.
- A theoretical 4-year window exists for implementing potentially curative therapies.
- While new therapies are crucial, this identified window offers hope for improved outcomes.